Look Forward – Winter 2022 – Issue 178
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
From our newsletters to the recordings of our webinars and everything in-between, use the filters (below) to find the content that's right for you.
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
We’re all still buzzing from our recent conferences. We do hope you enjoyed them as much as we did. If you weren’t able to join us, then you can watch or listen to the recordings on our website.
A general overview of the clinical trials process and practicalities, including issues to consider if you are given the opportunity to take part.
Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.